Kylo-11

· Kylonova (Xiamen) Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Kylo-11, covering 2026-03-16 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) [Phase 2]